EzempiloAmalungiselelo

Isidakamizwa esithi "i-Kurantil"

Isidakamizwa "i-Curantil" siyeka ukuhlanganiswa kwamaplatelet, kuthuthukise ukucubungula okuncane. Isidakamizwa sikwazi ukwandisa i-arterioles ye-coronary blood flow, ukukhulisa izinga layo lokuzivocavoca. Ukunciphisa izitsha ezinkulu akukwenzeka. Isidakamizwa esithi "i-Kurantil" sikwazi ukuthuthukisa ukubambisana, ukuqinisa izinso nokuthuthukisa ukugeleza kwegazi kwe-cerebral. Ukuthatha imithi kuvimbela ukwakheka kwe-thrombi emithanjeni ejulile ngemva kokuhlinzwa. Isithako esisebenzayo yi-dipyridamole.

Isidakamizwa "I-Kurantil" imfundo ivumela ukuqokwa ngesikhathi sokubeletha. Ngomkhuba wokuvimbela izidakamizwa, lesi sidakamizwa sikwazi ukuzinzisa ukugeleza kwegazi, ukuqeda i-hypoxia emathanjeni e-fetal, ukugqugquzela ukuqoqwa kwe-glycogen kuzo, kuvimbele izinguquko ku-placenta yesimo se-dystrophic. Futhi, izidakamizwa "i-Curantil" zandisa ukumelana (ukungaboni kahle) ukutheleleka kwegciwane.

Isithako esisebenzayo yisisetshenziswa se-pyrimidine. I-Dipiridamole, njengoba i-inducer ye-interferon, iyakwazi ukuba nomthelela wokumisa kumakhono asebenzayo ohlelweni lwe-interferon.

Umuthi "i-Kurantil." Imiyalo. Isiboniso.

Isidakamizwa sinqunyelwe i-prophylaxis kanye nezinhloso zokwelapha uma kwenzeka izinkinga zokujikeleza zoluhlobo lwe-ischemia, ne-encephalopathy ye-discirculatory. Imithi ikhonjiswe ekuvimbeleni izifo ezithinta izifo kanye nemiphumela yazo, ukungakwazi ukusebenza kwamakhemikhali ngokumelene nesisindo somzimba esiyinkimbinkimbi, i-thromboembolism emva kokungenelela kwamagciwane we-prosthetic heart. Ngomkhuhlane kanye ne-ARVI, imithi "i-Kurantil" imfundo ivumela ukuba isebenzise njenge-immunomodulator kanye ne-inducer ye-interferon. Imithi iboniswa ukuvimbela okuyisisekelo kanye nokubili kwe-IHD (ikakhulukazi lapho i-hypersensitivity kuya kwe-acetylsalicylic acid), ukuphazamiseka kwe-microcirculation yezinhlobonhlobo (ekuthathweni okuyinkimbinkimbi).

Umthamo wokulinganisa usungulwa ngokuhambisana nesimo sesiguli, ubunzima besifo.

Kunconywa i-IHD yamaphilisi amathathu kathathu ngosuku. Ukwandisa umthamo uma kunesidingo ngaphansi kokuqondiswa udokotela.

Ukwelapha nokuvimbela ukuphazamiseka kokusakazwa kwe-cerebral, kanye nokuvimbela ukwakheka kwe-thrombosis, kunconywa izikhathi ezintathu ngosuku nge-75 mg (amaphilisi amathathu).

Ukuze kuvikelwe izifo eziphefumulayo zokuphefumula nomkhuhlane, ikakhulukazi ngesikhathi sezifo eziwumshayabhuqe, umyalelo wezidakamizwa othi "i-Curantil" uncoma ukuthatha ama-50 mg (amaphilisi amabili) kanye kanye ngosuku, kanye ngesonto. Isikhathi sokusetshenziswa sisuka emavikini amane kuya kwahlanu.

Ukuvimbela ukubuyela emuva ezigulini ezitholakale ezifweni zokuphefumula ezithathelwanayo, imithi inqunywe amaphilisi amabili kabili ngosuku (ngekhefu lamahora amabili) kanye ngesonto. Isikhathi sokwamukelwa - amasonto ayisishiyagalombili noma ayishumi.

Ukusebenzisa lesi sidakamizwa "i-Curantil" ngesikhathi sokukhulelwa, umthamo uvame ukubekwa kanje: kabili noma kathathu ngosuku, ithebhulethi eyodwa.

Imithi kufanele ithathwe esiswini esingenalutho, igwinya yonke. Amathebulethi akufanele ahlolwe, kutuswa ukuba baphuze ngamanzi amancane.

Uma usebenzisa lesi sidakamizwa, ukuphendula okulandelayo kungenzeka: ukuhlanza, uhudo, ikhanda, imihlathi, isizungu, i-myalgia. Lapho kusetshenzwa ama-dide, ama-tachycardia (ikakhulukazi ngokumelene nokuthola amanye ama-vasodilating agents), i- hypotension yamagciwane ingabhalwa .

Kumele kuqashelwe ukuthi ukusetshenziswa kwezidakamizwa ezinanini eziphakanyisiwe, njengombuso, akubangeli imiphumela emibi noma kubangela ukusabela okungekho emthethweni okudlula ngokushesha ngisho nokusetshenziswa isikhathi eside kwesidakamizwa.

Mayelana nokwamukela izindlela "iKurantil" ekuphenduleni kokukhulelwa kungenzeka ukuhlangabezana nezihlukahlukene. Kwabesifazane abathile, lesi sidakamizwa asihambisani, kanti abanye, ngokuphambene nalokho, bazizwa kahle. Ngaphambi kokuba usebenzise imithi kuyadingeka ukuthi uxoxe nodokotela, ukuze ubone ukuthi kungenzeka yini ukuphikisana nokusetshenziswa.

Similar articles

 

 

 

 

Trending Now

 

 

 

 

Newest

Copyright © 2018 zu.delachieve.com. Theme powered by WordPress.